Lameditech Co (462510) Fair Value & Analysis
Healthcare · KR · Market cap 26.1B KRW
Fair value as of: Jun 24, 2026
Analysis
Lameditech Co (462510) currently trades at 2,895 KRW, while our model-based Fair Value estimate is 2,870 KRW — implying the stock looks roughly 0.9% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Lameditech Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. It offers laser lancing devices under the HandyRay-Lite and HandyRay names; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a device designed for the treatment of various skin diseases with its 308nm excimer light system; and Ray-Vet, a UVB light irradiation therapy system designed to treat inflammatory skin diseases and various auto-immune diseases in pets and animals. The company was founded in 2012 and is headquartered in Seoul, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Lameditech Co (462510) undervalued?
What is the fair value of 462510?
What is the quality score of 462510?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.